ARCHIVES

NCAB Delays Approval Of New Comprehensive Center Guidelines

This article is from The Cancer Letter archive.

Vol. 05 No. 41 | October 12, 1979

Download PDF Visit The Full Archive

Related Articles

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990